Research Roundup
Debbie Rigby rounds up the latest in research news Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes A large systematic review and network …
The debate goes on
AJP readers have reacted strongly to our recent story on pharmacists planning to quit the profession Our recent story ‘More pharmacists planning to quit’ has attracted a large number of …
Covid jab ‘going to go crazy’ in pharmacy
Pharmacies are set to receive up to $42 per person for administering the COVID vaccine, as groups welcome the invitation to participate in the rollout Community pharmacies are now invited …
Enhanced warnings
Boxed warnings are set to be added to the PI and CMI for medicines containing pregabalin and gabapentin These enhanced warnings advise that pregabalin poses a risk of misuse, while …
Praise for PBS expanded listing
More Australian adults can now access subsidised ADHD medication Vyvanse (lisdexamfetamine) From today (1 Feb), the Government has expanded the listing of Vyvanse (lisdexamfetamine) to include patients who are diagnosed …
CWH, Pharmacy 777 on watch list
Pharmacies are on the list of places visited by a man with a confirmed case of COVID-19 in WA WA Health has confirmed that a security guard working at a …
Inappropriate gestures, kiss lead to suspension
A GP has been reprimanded after he grabbed and kissed a pharmacy worker against her will The Medical Board of Australia has issued a statement about Dr Nigel Farrier, who …
‘You used to measure success by how many scripts you could dispense that day.’
“Not just putting stickers on a box”: How much has pharmacy really changed over the years? Leading pharmacists weigh in Community pharmacy has changed significantly over the past few decades …
Asthma conversations
Medication reviews are an opportunity for pharmacists to assess a person’s asthma control and inhaler device technique in the privacy of their home and integrate shared decision making for optimal …
Delirium and deprescribing
Despite being a common condition, delirium is poorly recognised, and cases are often missed. As medications are one of the most common causes of delirium, pharmacists and general practitioners have …
Medicinal cannabis: the current state of play
Despite the accumulating body of scientific knowledge about, and the growing demand for access to products derived from medicinal cannabis, there is still an absence of the clinical trial data …
The week in review
COVID vaccination was a key issue this week, as well as the future of pharmacy, as NAPSA held its annual congress There was big news from the Morrison Government this …